Sales 2024 * | 25.16M 34.24M | Sales 2025 * | 81.93M 111M | Capitalization | 286M 389M |
---|---|---|---|---|---|
Net income 2024 * | -41M -55.8M | Net income 2025 * | -1M -1.36M | EV / Sales 2024 * | 8.22 x |
Net cash position 2024 * | 78.97M 107M | Net cash position 2025 * | 67.68M 92.11M | EV / Sales 2025 * | 2.66 x |
P/E ratio 2024 * |
-7.43
x | P/E ratio 2025 * |
-109
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.08% |
Latest transcript on CorMedix Inc.
Managers | Title | Age | Since |
---|---|---|---|
Joseph Todisco
CEO | Chief Executive Officer | 48 | 22-03-17 |
Mathew David
DFI | Director of Finance/CFO | 47 | 20-05-10 |
Tushar Mukherjee
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Myron Kaplan
CHM | Chairman | 79 | 16-04-26 |
Steven Lefkowitz
DFI | Director of Finance/CFO | 68 | 11-08-14 |
Alan Dunton
BRD | Director/Board Member | 70 | 19-02-28 |
1st Jan change | Capi. | |
---|---|---|
+10.23% | 9.11B | |
-10.76% | 5.21B | |
+51.58% | 4.83B | |
+12.50% | 4.09B | |
-20.70% | 2.35B | |
+12.83% | 2.32B | |
+19.51% | 2.27B | |
-29.65% | 2.19B | |
-0.50% | 1.64B |